Literature DB >> 24423978

Adrenocortical carcinoma.

Tobias Else1, Alex C Kim, Aaron Sabolch, Victoria M Raymond, Asha Kandathil, Elaine M Caoili, Shruti Jolly, Barbra S Miller, Thomas J Giordano, Gary D Hammer.   

Abstract

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable prognosis. Here we summarize the knowledge about diagnosis, epidemiology, pathophysiology, and therapy of ACC. Over recent years, multidisciplinary clinics have formed and the first international treatment trials have been conducted. This review focuses on evidence gained from recent basic science and clinical research and provides perspectives from the experience of a large multidisciplinary clinic dedicated to the care of patients with ACC.

Entities:  

Mesh：

Year:  2013        PMID： 24423978      PMCID： PMC3963263          DOI： 10.1210/er.2013-1029

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


  380 in total

1.  D.D.D. therapy in Cushing's syndrome.

Authors:  H L SHEEHAN; V K SUMMERS; J NICHOLS
Journal:  Lancet       Date:  1953-02-14       Impact factor: 79.321

2.  Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.

Authors:  Ricardo J Gonzalez; Suzanne Shapiro; Nicholas Sarlis; Rena Vassilopoulou-Sellin; Nancy D Perrier; Douglas B Evans; Jeffrey E Lee
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

3.  Embolization of nonliver visceral tumors.

Authors:  Paul G Thacker; Jeremy L Friese; Matthew Loe; Peter Biegler; Michael Larson; James Andrews
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

4.  Effects of insulin-like growth factor I (IGF-I) on enzymatic activity in human adrenocortical cells. Interactions with ACTH.

Authors:  M T Pham-Huu-Trung; J M Villette; A Bogyo; J M Duclos; J Fiet; M Binoux
Journal:  J Steroid Biochem Mol Biol       Date:  1991-12       Impact factor: 4.292

5.  Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Authors:  Alfredo Berruti; Massimo Terzolo; Paola Sperone; Anna Pia; Silvia Della Casa; David J Gross; Carlo Carnaghi; Paolo Casali; Francesco Porpiglia; Franco Mantero; Giuseppe Reimondo; Alberto Angeli; Luigi Dogliotti
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

Review 6.  Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature.

Authors:  Aaron Scott Wagner; Julie M Fleitz; B K Kleinschmidt-Demasters
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

7.  Neurofibromatosis in childhood.

Authors:  N L Fienman; W C Yakovac
Journal:  J Pediatr       Date:  1970-03       Impact factor: 4.406

8.  Adrenocortical carcinoma: surgical progress or status quo?

Authors:  M L Kendrick; R Lloyd; L Erickson; D R Farley; C S Grant; G B Thompson; C Rowland; W F Young; J A van Heerden
Journal:  Arch Surg       Date:  2001-05

9.  An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors.

Authors:  A C Latronico; E M Pinto; S Domenice; M C Fragoso; R M Martin; M C Zerbini; A M Lucon; B B Mendonca
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

10.  Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth.

Authors:  E Wolf; R Kramer; W F Blum; J Föll; G Brem
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736
View more
  243 in total

Review 1.  5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications.

Authors:  Sarika N Rao; Mouhammed Amir Habra
Journal:  Horm Cancer       Date:  2015-12-10       Impact factor: 3.869

2.  Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.

Authors:  Toyoyoshi Uchida; Koshiro Nishimoto; Yuki Fukumura; Miki Asahina; Hiromasa Goto; Yui Kawano; Fumitaka Shimizu; Akira Tsujimura; Tsugio Seki; Kuniaki Mukai; Yasuaki Kabe; Makoto Suematsu; Celso E Gomez-Sanchez; Takashi Yao; Shigeo Horie; Hirotaka Watada
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

Review 3.  Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.

Authors:  R Armignacco; G Cantini; L Canu; G Poli; T Ercolino; M Mannelli; M Luconi
Journal:  J Endocrinol Invest       Date:  2017-10-28       Impact factor: 4.256

4.  Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells.

Authors:  Matthias Kroiss; Silviu Sbiera; Sabine Kendl; Max Kurlbaum; Martin Fassnacht
Journal:  Horm Cancer       Date:  2016-09-08       Impact factor: 3.869

5.  Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Authors:  C Christofer Juhlin; Gerald Goh; James M Healy; Annabelle L Fonseca; Ute I Scholl; Adam Stenman; John W Kunstman; Taylor C Brown; John D Overton; Shrikant M Mane; Carol Nelson-Williams; Martin Bäckdahl; Anna-Carinna Suttorp; Matthias Haase; Murim Choi; Joseph Schlessinger; David L Rimm; Anders Höög; Manju L Prasad; Reju Korah; Catharina Larsson; Richard P Lifton; Tobias Carling
Journal:  J Clin Endocrinol Metab       Date:  2014-12-09       Impact factor: 5.958

Review 6.  Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Authors:  Ozgur Mete; Sylvia L Asa; Thomas J Giordano; Mauro Papotti; Hironobu Sasano; Marco Volante
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 7.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

8.  Characteristic CT features of pheochromocytomas - probability model calculation tool based on a multicentric study.

Authors:  Filip Ctvrtlik; Zbynek Tudos; Paulina Szasz; Zuzana Sedlackova; Igor Hartmann; Jan Schovanek; Zdenek Frysak; Iva Macova; Tomas Zelinka; Milan Hora; Eva Kocova; Jaroslav Pacovsky; Michal Krsek; Viera Lehotska; Emilia Mojtova; Josef Molnar; Vladimir Vanek; Karel Pacak; Jan Baxa
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2019-09-23       Impact factor: 1.245

Review 9.  Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.

Authors:  Morgan K Penny; Isabella Finco; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2016-12-08       Impact factor: 4.102

10.  Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.

Authors:  Liem M Phan; Enrique Fuentes-Mattei; Weixin Wu; Guermarie Velazquez-Torres; Kanishka Sircar; Christopher G Wood; Tao Hai; Camilo Jimenez; Gilbert J Cote; Levent Ozsari; Marie-Claude Hofmann; Siyuan Zheng; Roeland Verhaak; Lance Pagliaro; Maria Angelica Cortez; Mong-Hong Lee; Sai-Ching J Yeung; Mouhammed Amir Habra
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.